G&A Expense -- $1.9 million, down from $2.3 million mainly due to lower compensation and recruitment spending. Cash on ...
Commercial Metals (NYSE:CMC) executives said fiscal 2026 opened with “one of the best” first quarters in the company’s ...
VANCOUVER, BC / ACCESS Newswire / January 8, 2026 /SILVER X MINING CORP. (TSXV:AGX)(OTCQB:AGXPF)(F:AGX) ("Silver X" or the ...
Super Micro Computer’s $2B credit facility boosts liquidity but raises leverage and margin concerns amid AI demand.
Q1 2026 Earnings Call Transcript January 7, 2026 MSC Industrial Direct Co., Inc. beats earnings expectations. Reported EPS is ...
Though the chain reported -2.5% same-store sales during its first quarter, it experienced sequential traffic growth despite a ...
Prestigious Annual Awards Program Celebrates a Decade of Recognizing Top Internet-of-Things Innovators Around the Globe ...
Days after a citizen initiative qualified for the November ballot, Governor Tina Kotek called on lawmakers Wednesday to ...
VANCOUVER, BC / ACCESS Newswire / / SILVER X MINING CORP. (TSXV:AGX )(OTCQB:AGXPF )(F:AGX) ("Silver X" or the "Company"), is ...
GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, ...
DuPont's recent spinoff of its Electronics segment and sale of the Aramids business aim to streamline operations. Read why DD ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback